utah medical products
-
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
-
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022
UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in…
-
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021
The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
